◀ Back to HMGB1

HMGB1 — RNF19A

Text-mined interactions from Literome

Kawahara et al., Cardiovasc Pathol 2008 (Inflammation) : C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells
Yuk et al., Antioxid Redox Signal 2009 (Inflammation) : In addition, HMGB1 induced activation of p38 and c-Jun N-terminal kinase (JNK), but not extracellular signal regulated kinase 1/2, was strongly abrogated by the overexpression of APE1 ... In addition, HMGB1 induced activation of p38 and c-Jun N-terminal kinase (JNK), but not extracellular signal regulated kinase 1/2, was strongly abrogated by the overexpression of APE1
Kawahara et al., Int J Mol Med 2008 (Atherosclerosis...) : The p38MAPK inhibitor SB203580 and the 5-HT1B antagonist GR55526 markedly inhibited HMGB1 release from 5-HT stimulated HUVECs
Nadatani et al., Am J Pathol 2012 (Peptic Ulcer) : In wild-type mice, recombinant human HMGB1 aggravated indomethacin induced small intestinal damage ; enhanced the mRNA expression levels of tumor necrosis factor a (TNF-a), monocyte chemotactic protein 1, and KC ; activated nuclear factor kappa B ; and stimulated phosphorylation of the mitogen activated protein kinases p38 , extracellular signal regulated kinase ( ERK ), and c-Jun N-terminal kinase (JNK)